Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Oxford Biomedica plc · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $414.48M | $402.61M - $427.90M | -$95.71M | $0.433 | 3 |
| Dec 2028 | $336.10M | $334.07M - $338.14M | -$77.61M | $0.371 | 7 |
| Dec 2027 | $287.63M | $278.65M - $297.52M | -$66.42M | $0.113 | 8 |
| Dec 2026 | $227.87M | $222.09M - $234.67M | -$52.62M | -$0.121 | 8 |
| Dec 2025 | $167.14M | $164.81M - $169.46M | -$38.59M | -$0.289 | 6 |
| Dec 2024 | $127.74M | $124.93M - $131.50M | -$59.97M | -$0.446 | 8 |
| Dec 2023 | $97.28M | $94.50M - $100.43M | -$22.46M | -$1.408 | 7 |
| Dec 2022 | $130.04M | $124.53M - $135.55M | -$38.15M | -$0.182 | 6 |
| Dec 2021 | $155.52M | $144.47M - $161.62M | -$37.76M | $0.226 | 7 |
| Dec 2020 | $86.90M | $80.72M - $90.30M | -$26.16M | -$0.057 | 7 |
| Dec 2019 | $65.20M | $60.56M - $67.75M | $446.0K | -$0.197 | 6 |
| Dec 2018 | $63.25M | $58.76M - $65.73M | -$25.93M | $0.087 | 3 |